An epidemiologic and therapeutic reassessment of scabies

Cutis

Volumn 65, Issue 4, 2000, Pages 233-240

  Burkhart, Craig G ^a   Burkhart, Craig N ^a   Burkhart, Kristiina M ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; IVERMECTIN;

ANIMAL; FEMALE; HUMAN; MITE; PATHOLOGY; REVIEW; SCABIES;

ANIMALS; ANTIPROTOZOAL AGENTS; FEMALE; HUMANS; IVERMECTIN; MITES; SCABIES;

EID: 0034171172     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Barrett NJ, Morse DL: The resurgence of scabies. CDR Rev 3: 32-34, 1993.
2. Estes SA, Arlian L: Survival of Sarcoptes scabiei. J Am Acad Dermatol 5: 343, 1981.
3. Arlian LG, Runyan RA, Achar S, et al: Survival and infestivity of Sarcoptes scabiei var. canis and var hominis. J Am Acad Dermatol 11: 210-215, 1984.
4. Ong GP, Bhatia SG: Survival of Sarcoptes scabiei. J Am Acad Dermatol 6: 115-116, 1982.
5. Estes SA, Estes J: Therapy of scabies: nursing homes, hospitals, and the homeless. Semin Dermatol 12: 26-33, 1993.
6. Arlian LG, Runyan RA, Sorlie LB, et al: Host-seeking behavior of Sarcoptes scabiei. J Am Acad Dermatol 11: 594-598, 1984.
7. Mellanby K: Scabies. Hampton, England, EW Classey, Ltd, 1972.
8. Johnson CG, Mellanby K: The parasitology of human scabies. Parasitology 34: 285-290, 1942.
9. Burkart CG: Scabies: an epidemiologic reassessment. Ann Intern Med 98: 498-503, 1983.
10. Meinking TL, Taplin D, Hermida JL, et al: The treatment of scabies with ivermectin. N Engl J Med 333: 26-30, 1995.
11. Spach DH, Fritsche TR: Norwegian scabies in a patient with AIDS. N Engl J Med 331: 777, 1994.
12. Portu JJ, Santamaria JM, Zubero Z, et al: Atypical scabies in HIV-positive patients. J Am Acad Dermatol 34: 915-917, 1996.
13. Sirera G, Rius F, Romev J, et al: Hospital outbreak of scabies stemming from two AIDs patients with Norwegian scabies. Lancet 335: 1227, 1990.
14. Carslaw RW: Scabies in a spinal injuries unit. Br Med J 1: 617, 1975.
15. Arlian LG, Estes SA, Vyszenski-Moher DL: Prevalence of Sarcoptes scabiei in the homes and nursing homes of scabietic patients. J Am Acad Dermatol 19: 806-811, 1988.
16. Hewitt M, Barrow GI, Miller DC, et al: Mites in the personal environment and their role in skin disorders. Br J Dermatol 89:401-409, 1973.
17. Holness DL, DeKouejn JG, Nethercott JR: Scabies in chronic health care institutions. Arch Dermatol 128: 1257-1260, 1992.
18. Jimenez-Oucho VE, Fallon F, Caputo C, et al: Role of prolonged surveillance in the eradication of nosocomial scabies in an extended care Veterans Affairs medical center. Am J Infect Control 23: 44-49, 1995.
19. Mahe A, Pruual A, Konate M, et al: Skin diseases of children in Mali: public health problem. Trans R Soc Trop Med Hyg 89: 467-470, 1995.
20. Blumenthal DS, Taplin D, Schultz MG: A community outbreak of scabies. Am J Epidemiol 104: 667-672, 1976.
21. Orkin M: Today's scabies. JAMA 233: 882-885, 1975.
22. Andrews JRH: Scabies in New Zealand. Int J Dermatol 18: 545-552, 1979.
23. Carslaw RW, Dobson RM, Hood AJK, et al: Mites in the environment of cases of Norwegian scabies. Br J Dermatol 92: 333-337, 1975.
24. Estes SA: The Diagnosis and Management of Scabies, pp 1-21. Piscataway, NJ, Reed and Carnrick, 1981.
25. Taplin D, Meinking TL: Pyrethrins and pyrethroids in dermatology. Arch Dermatol 126: 213-221, 1990.
26. Rasmussen JE: Lindane: a prudent approach. Arch Dermatol 123: 1008-1010, 1987.
27. Campball WC (ed): Ivermectin and Abamectin, pp 149-161, 215-229. New York, Springer-Verlag, 1989.
28. Greene AM, Brown KR, Taylor HR: Use of ivermectin in humans. In, Ivermectin and Abamectin (Campbell WC, ed), pp 311-323. New York, Springer-Verlag, 1989.
29. Aubin F, Humbert P: Ivermectin for crusted (Norwegian) scabies [letter]. N Engl J Med 132: 612, 1995.
30. Greene BM, Taylor HR, Cupp EW, et al.: Comparisons of ivermectin and diethylcarbazine in the treatment of onchocerciasis. N Engl J Med 313: 133-138, 1985.
31. Caumes E, Datry A, Paris L, et al.: Efficacy of ivermectin in the therapy of cutaneous larva migrans. Arch Dermatol 128: 994-995, 1992.
32. Martin-Prevel Y, Cosnegroy JY, Tshipamha P, et al: Tolerance and efficacy of single high-dose ivermectin for the treatment of loiasis. Am J Trop Med Hyg 48: 186-192, 1993.
33. Cartel JL, Nguyen NL, Moulia-Pèltat JP, et al: Mass chemoprophylaxis of lymphatic filariasis with a single dose of ivermectin in a Polynesian community with a high Wuchereria bancrofti infection rate. Trans R Soc Trop Med Hyg 86: 537-540, 1992.
34. Glaziou P, Cartel JL, Alzieu P, et al: Comparison of ivermectin and benzyl benzoate for treatment of scabies. Trop Med Parasitol 44: 331-332, 1993.
35. Kar SK, Mania J, Patnaik S: The use of ivermectin for scabies. Natl Med J India 7: 15-16, 1994.
36. Dunne CL, Malone CJ, Whitworth JAG: A field study of the effects of ivermectin on ectoparasites of man. Trans R Soc Trop Med Hyg 85: 550-551, 1991.
37. Macotela-Ruiz E, Pena-Gonzalez G: Tratamiento de la escabiasis con ivermectina por via oral. Gaceta Medica de Mexico 129: 201-205, 1993.
38. Marry P, Gari-Toussaint M, LeFichoux Y, et al: Efficacy of ivermectin in the treatment of an epidemic of sarcoptes scabies. Ann Trop Med Parositol 88: 453, 1994.
39. Barkwell R, Shields S: Deaths associated with ivermectin treatment of scabies. Lancet 349: 1144-1145, 1997.
40. Burkhart KM, Burkhart CN, Burkhart CG: Update on therapy: ivermectin is available for use in lice [letter]. Infect Med 14: 689, 1997.
41. Burkhart KM, Burkhart CN, Burkhart CG: Comparing topical scabetic treatment will soon become extinct. Arch Dermatol 133: 1314, 1997.